A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/15803001

Download in:

View as

General Info

PMID
15803001